David J. Ross, M.D.
Professor of Medicine
Physician, Pulmonary and Critical Care Medicine
Medical Director, Lung and Heart-Lung Transplant Program

Address:
Division of Pulmonary and Critical Care Medicine
David Geffen School of Medicine at UCLA
37-131 Center for Health Sciences
10833 Le Conte Avenue
Los Angeles, CA 90095-1690

Phone:
Lung Center Messages: 310-206-7858
Prescription Refills: 310-206-0863
Appointments: 310-825-8061
Academic Office: 310-794-9458
Emergency: 310-825-6301 (UCLA page operator)
FAX: 310-206-8622

Email:

dross@mednet.ucla.edu

<<back to faculty main

Education and Training

Fellowship: Pulmonary Disease: Cedars-Sinai Medical Center, 1986-1989

Residency: Internal Medicine: Cedars-Sinai Medical Center, 1984-1986

Internship: Internal Medicine: Cedars-Sinai Medical Center, 1983-1984

Medical Degree: M.D.: USC School of Medicine, 1983

>>back to top

Areas of Interest

Lung Transplant
Pulmonary Hypertension

>>back to top
Representative Publications:

Ross DJ, Marchevsky A, Kass RM.Ý "Nonspecific chronic inflammation" in lung allografts:Ý Association with respiratory pathogens. Transplantation Proceedings 28(5):2983-2986, 1996.

Ross DJ, Marchevsky A, Kramer M, Kass RM.Ý "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.Ý Journal of Heart and Lung Transplantation 16(8):832-838, 1997.

Barst RJ, Rubin LJ, Long WA (acknowledgment).Ý A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.Ý NEJM 334:296-301, 1996

Ross DJ, Lewis MI, Kramer M, Vo A, Kass RM, Koerner S.Ý FK506 "rescue" immunosuppression for obliterative bronchiolitis after lung transplantation.Ý Chest 112:1175, 1997.

Ross DJ, Kass RM, Mohsenifar Z.Ý Assessment of regional VA/Q relationships by SPECT after single lung transplantation.Ý Transplantation Proceedings 30:180-186, 1998.

Mentzer RM, Jahania MS, Lasley RD, and the US Multicenter FK506 Study Group (acknowledgment, multicenter study).Ý Tacrolimus as a rescue immunosuppressant after heart and lung transplantation.Ý Transplantation 65:109-113, 1998.

Biring MS, Fournier M, Ross DJ, Lewis MI.Ý Cellular adaptations of skeletal muscle to cyclosporine.Ý J Appl Physiol, 84(6):1967-75, 1998.

Ross DJ, Waters PF, Levine M, Kramer M, Ruzevich S, Kass RM. Mycophenolate Mofetil (MMF; Cellcept) versus Azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.Ý Journal of Heart and Lung Transplantation 17(8):768-74,1998.

Ross DJ, Moudgil A, Bagga A, Toyoda M, Marchevsky AM, Kass RM, Jordan SC. Lung allograft dysfunction correlates with g-interferon gene expression in bronchoalveolar lavage. Journal of Heart and Lung Transplantation 1999; 18:627-36.

Moudgil A, Bagga A, Toyoda M, Nicolaidou E, Jordan SC, Ross D. Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients. Clinical Transplantation 1999; 13(2):201-7.

Garone S & Ross DJ. Bronchiolitis Obliterans:Ý review of our knowledge and treatment strategies.Ý Curr Opin Organ Transplant 1999; 4:254-63.

Ross DJ and Kass RM.Ý Monitoring for lung allograft rejection;

Ross DJ and Kass RM.Ý Treatment of acute allograft rejection;

Madison S, Ross DJ, Kass RM.Ý Management of the patients awaiting lung transplantation.Ý IN: Heart and Lung Transplantation.Ý Ed William A. Baumgartner, M.D., Edward K. Kasper, M.D., James Theodore, M.D. and Bruce Reitz, M.D.Ý In press, WB Saunders Inc. 1998.

>>back to top , faculty main
 

Copyright © 2003
University of California at Los Angeles